-
公开(公告)号:US20230183820A1
公开(公告)日:2023-06-15
申请号:US17870506
申请日:2022-07-21
申请人: HELIXBIND, INC.
发明人: Alon Singer , Ranjit Prakash , Srinivas Rapireddy , Jork Nolling
IPC分类号: C12Q1/689 , C12Q1/6806 , C12N15/10 , B01L3/00
CPC分类号: C12Q1/689 , C12Q1/6806 , C12N15/101 , B01L3/502715 , B01L3/502738 , B01L3/502753 , B01L2200/028 , B01L2200/0631 , B01L2200/16 , B01L2300/087 , B01L2300/0877 , B01L2400/0487 , B01L2400/0633 , C12Q2600/158 , C12Q2600/16
摘要: Methods and devices for isolating microbial cells from a sample, extracting eukaryotic DNA from a sample, and identifying the microbial species in the sample are disclosed herein.
-
公开(公告)号:US20210260588A1
公开(公告)日:2021-08-26
申请号:US17183897
申请日:2021-02-24
申请人: HelixBind, Inc.
发明人: Alon Singer , Ranjit Prakash , David Steinmiller
IPC分类号: B01L3/00
摘要: Fluidic systems and reagent carriers suitable for storing reagents in a desirable manner are generally provided. In some embodiments, a reagent carrier stores a liquid film comprising a solid reagent and/or stores different reagents in different locations. In some embodiments, a fluidic system comprises a reagent carrier constrained such that it comprises an elongated axis positioned within 30° of a vertical axis of the fluidic reservoir.
-
公开(公告)号:US20170292146A1
公开(公告)日:2017-10-12
申请号:US15511957
申请日:2015-09-17
申请人: HELIXBIND, INC.
发明人: Alon Singer , Ranjit Prakash , Srinivas Rapireddy , Jork Nolling
CPC分类号: C12Q1/689 , B01L3/502715 , B01L3/502738 , B01L3/502753 , B01L2200/028 , B01L2200/0631 , B01L2200/16 , B01L2300/087 , B01L2300/0877 , B01L2400/0487 , B01L2400/0633 , C12N15/101 , C12Q1/6806 , C12Q2600/158 , C12Q2600/16
摘要: Methods and devices for isolating microbial cells from a sample, extracting eukaryotic DNA from a sample, and identifying the microbial species in the sample are disclosed herein.
-
公开(公告)号:US09663830B2
公开(公告)日:2017-05-30
申请号:US14402028
申请日:2013-05-17
申请人: HELIXBIND
发明人: Alon Singer
IPC分类号: C12Q1/68
CPC分类号: C12Q1/689 , C12Q1/6816 , C12Q1/6883 , C12Q1/6895 , C12Q2600/158 , C12Q2600/16 , C12Q2525/107 , C12Q2537/143 , C12Q2565/519 , C12Q2565/625
摘要: The present disclosure provides for composition of γPNA probes. Additionally, the present disclosure provide for methods and kits using γPNA probes for the prognosis of sepsis. In some embodiments, wherein the γPNA capture probes and γPNA reporter probes comprise one or more functional moiety selected from the group consisting of: a binding molecule, a spacer group, a linker group, a hydrophobicity-changing group, a charge-inducing group, and a structural charge-inducing group.
-
公开(公告)号:US20240068050A1
公开(公告)日:2024-02-29
申请号:US18488632
申请日:2023-10-17
申请人: HelixBind, Inc.
发明人: Alon Singer , Ranjit Prakash , Jork Nolling
IPC分类号: C12Q1/689 , C12Q1/6895
CPC分类号: C12Q1/689 , C12Q1/6895
摘要: The present disclosure generally relates to the field of microbial pathogen detection and identification utilizing genomic sequence recognition.
-
公开(公告)号:US20230173494A1
公开(公告)日:2023-06-08
申请号:US18101870
申请日:2023-01-26
申请人: HelixBind, Inc.
发明人: Alon Singer , Ranjit Prakash , David Steinmiller
IPC分类号: B01L3/00
CPC分类号: B01L3/52 , B01L3/502 , B01L2200/16 , B01L2300/0861 , B01L2200/06 , B01L2300/0848 , B01L2200/026
摘要: Fluidic systems and reagent carriers suitable for storing reagents in a desirable manner are generally provided. In some embodiments, a reagent carrier stores a liquid film comprising a solid reagent and/or stores different reagents in different locations. In some embodiments, a fluidic system comprises a reagent carrier constrained such that it comprises an elongated axis positioned within 30° of a vertical axis of the fluidic reservoir.
-
公开(公告)号:US11414712B2
公开(公告)日:2022-08-16
申请号:US15511957
申请日:2015-09-17
申请人: HELIXBIND, INC.
发明人: Alon Singer , Ranjit Prakash , Srinivas Rapireddy , Jork Nolling
IPC分类号: C12Q1/689 , C12Q1/6806 , C12N15/10 , B01L3/00
摘要: Methods and devices for isolating microbial cells from a sample, extracting eukaryotic DNA from a sample, and identifying the microbial species in the sample are disclosed herein.
-
公开(公告)号:US11091814B2
公开(公告)日:2021-08-17
申请号:US15488204
申请日:2017-04-14
申请人: HELIXBIND, INC.
发明人: Alon Singer
IPC分类号: C12Q1/689 , C12Q1/6816 , C12Q1/6883 , C12Q1/6895
摘要: The present disclosure provides for compositions of γPNA probes. Additionally, the present disclosure provide for methods and kits using γPNA probes for the diagnosis of sepsis.
-
公开(公告)号:US10730041B2
公开(公告)日:2020-08-04
申请号:US15458288
申请日:2017-03-14
申请人: HelixBind, Inc.
发明人: Alon Singer , Ranjit Prakash
摘要: Fluidic devices and related methods are generally provided. The fluidic devices described herein may be useful, for example, for diagnostic purposes (e.g., detection of the presence of one or more disease causing bacteria in a patient sample). Unlike certain existing fluidic devices for diagnostic purposes, the fluidic devices and methods described herein may be useful for detecting the presence of numerous disease causing bacteria in a patient sample substantially simultaneously (e.g., in parallel). In some embodiments, the fluidic devices and methods described herein provide highly sensitive detection of microbes in relatively large fluidic samples (e.g., between 0.5 mL and about 5 mL), as compared to certain existing fluidic detection (e.g., microfluidic) devices and methods. In an exemplary embodiment, increased detection sensitivity of microbial pathogens present in a patient sample (e.g., blood) is performed by selectively removing human nucleic acid prior to sensitive detection of microbial infection. In some embodiments, the fluidic device allows for the identification of microbial pathogens directly from unprocessed blood without having to conduct blood culturing processes.
-
公开(公告)号:US20170259257A1
公开(公告)日:2017-09-14
申请号:US15458288
申请日:2017-03-14
申请人: HelixBind, Inc.
发明人: Alon Singer , Ranjit Prakash
摘要: Fluidic devices and related methods are generally provided. The fluidic devices described herein may be useful, for example, for diagnostic purposes (e.g., detection of the presence of one or more disease causing bacteria in a patient sample). Unlike certain existing fluidic devices for diagnostic purposes, the fluidic devices and methods described herein may be useful for detecting the presence of numerous disease causing bacteria in a patient sample substantially simultaneously (e.g., in parallel). In some embodiments, the fluidic devices and methods described herein provide highly sensitive detection of microbes in relatively large fluidic samples (e.g., between 0.5 mL and about 5 mL), as compared to certain existing fluidic detection (e.g., microfluidic) devices and methods. In an exemplary embodiment, increased detection sensitivity of microbial pathogens present in a patient sample (e.g., blood) is performed by selectively removing human nucleic acid prior to sensitive detection of microbial infection. In some embodiments, the fluidic device allows for the identification of microbial pathogens directly from unprocessed blood without having to conduct blood culturing processes.
-
-
-
-
-
-
-
-
-